Cancer Research UK logo.
SearchDonate
  • Search

A trial looking at decitabine and carboplatin for advanced ovarian cancer (DACROC)

Overview

Cancer types:

Ovarian cancer

Status:

Results

Phase:

Phase 2

Details

This trial compared a combination of the chemotherapy drugs decitabine and carboplatin with carboplatin alone for ovarian cancer that has come back. This trial was supported by Cancer Research UK.

Recruitment start: 23 July 2007

Recruitment end: 18 December 2008

How to join

Please note: In order to join a trial you will need to discuss it with your doctor, unless otherwise specified.

Chief investigators

Professor Stan Kaye

Supported by

Cancer Research UK (Centre for Drug Development)

Experimental Cancer Medicine Centre (ECMC)

NIHR Clinical Research Network: Cancer

Other information

This is Cancer Research UK trial number CRUKD/07/065.

Last reviewed: 16 July 2014

CRUK internal database number: 729

The Dangoor Education logo.

Dangoor Education

About Cancer generously supported by Dangoor Education since 2010. Learn more about Dangoor Education

Patient Information Forum. Trusted Information Creator.
Plain English Campaign award.

Help and support

An icon of a hand shake.

Questions for your doctor

What to ask your doctor about clinical trials.

Search
An icon of two speech bubbles, indicating a conversation.

Cancer chat forum

Meet and chat to other cancer people affected by cancer.

Join
An icon of a landline phone.

Nurse helpline

Questions about cancer? Call freephone 0808 800 40 40 from 9 to 5 - Monday to Friday. Alternatively, you can email us.

Talk